Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma (NCT-PMO-1601)

NCT03110744 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.

NCT NCT03110744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03110744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma (NCT-PMO-1601)
Lead sponsor
University Hospital Heidelberg
Phase
Phase 2
Overall status
Completed
Start date
December 15, 2017
Completion date
December 22, 2022
Enrollment
43 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chordoma